Familial partial lipodystrophy
| Familial partial lipodystrophy | |
|---|---|
| Synonyms | FPLD |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Loss of subcutaneous fat, insulin resistance, hypertriglyceridemia, acanthosis nigricans, polycystic ovary syndrome |
| Complications | Diabetes mellitus, cardiovascular disease, non-alcoholic fatty liver disease |
| Onset | Childhood or adolescence |
| Duration | Lifelong |
| Types | Dunnigan-type familial partial lipodystrophy, Köbberling-type familial partial lipodystrophy, Mandel's type familial partial lipodystrophy |
| Causes | Genetic mutations (e.g., LMNA, PPARG, AKT2) |
| Risks | Family history |
| Diagnosis | Clinical evaluation, genetic testing |
| Differential diagnosis | Cushing's syndrome, metabolic syndrome, HIV-associated lipodystrophy |
| Prevention | N/A |
| Treatment | Diet, exercise, metformin, insulin sensitizers, lipid-lowering agents |
| Medication | Metformin, thiazolidinediones, fibrates |
| Prognosis | N/A |
| Frequency | Rare |
| Deaths | |
Familial partial lipodystrophy (FPL) is a rare genetic disorder characterized by the selective loss of subcutaneous fat from various parts of the body. This condition is inherited in an autosomal dominant manner, meaning one copy of the altered gene in each cell is sufficient to cause the disorder.
Symptoms[edit]
The symptoms of familial partial lipodystrophy typically become noticeable during puberty. Affected individuals often have a lack of fatty tissue in the arms, legs, and trunk, and may have excessive fat deposits in the face and neck. Other symptoms may include insulin resistance, hypertriglyceridemia, hypertension, and diabetes mellitus.
Causes[edit]
Familial partial lipodystrophy is caused by mutations in the LMNA or PPARG genes. These genes provide instructions for making proteins that are involved in the regulation of fat cell differentiation and growth.
Diagnosis[edit]
Diagnosis of familial partial lipodystrophy is based on the clinical symptoms, family history, and genetic testing. Genetic testing can confirm the diagnosis and identify the specific gene mutation.
Treatment[edit]
Treatment for familial partial lipodystrophy is focused on managing the symptoms and preventing complications. This may include lifestyle modifications, medication to control diabetes and high cholesterol, and in some cases, plastic surgery to improve appearance.
See also[edit]
References[edit]
<references />
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


